Back to Search
ARUN RAJASEKARAN, MD
MD
Nephrology Physician
NPI: 1386028025IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
37198(AL)MD2024-0970(NM)
CMS Specialties
PrimaryNEPHROLOGY
Education
OTHER
Class of 2011
Research & Publications (20)
Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin.
PMID 19322565·Cancer Chemother Pharmacol·2009
7-preclinical
Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin.
PMID 18303430·J Thorac Oncol·2008
3-trial
Na,K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma.
PMID 18006011·J Urol·2008
8-other
alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling.
PMID 18566211·Mol Cancer Ther·2008
8-other
Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability.
PMID 18645024·Mol Cancer Ther·2008
7-preclinical
Evidence for a potential tumor suppressor role for the Na,K-ATPase beta1-subunit.
PMID 18228203·Histol Histopathol·2008
7-preclinical
Interactions of tight junctions with membrane channels and transporters.
PMID 18086552·Biochim Biophys Acta·2008
6-review
Preferential association of prostate cancer cells expressing prostate specific membrane antigen to bone marrow matrix.
PMID 17332929·Int J Oncol·2007
8-other
Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer.
PMID 17237818·Oncogene·2007
8-other
Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2.
PMID 17912448·Int J Oncol·2007
7-preclinical
Clinical trials of cancer therapies targeting prostate-specific membrane antigen.
PMID 18474004·Rev Recent Clin Trials·2007
6-review
Na-K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells.
PMID 16959951·Am J Physiol Gastrointest Liver Physiol·2007
8-other
Janus model of the Na,K-ATPase beta-subunit transmembrane domain: distinct faces mediate alpha/beta assembly and beta-beta homo-oligomerization.
PMID 17078968·J Mol Biol·2007
7-preclinical
Differing effects of microtubule depolymerizing and stabilizing chemotherapeutic agents on t-SNARE-mediated apical targeting of prostate-specific membrane antigen.
PMID 17041090·Mol Cancer Ther·2006
7-preclinical
Effect of a multidisciplinary lung investigation day on a rapid access lung cancer service.
PMID 16754713·Postgrad Med J·2006
8-other
Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years.
PMID 16758510·J Rheumatol·2006
4-observational
Antibacterial, antifungal and anticonvulsant evaluation of novel newly synthesized 1-[2-(1H-tetrazol-5-yl)ethyl]-1H-benzo[d][1, 2,3]triazoles.
PMID 16903071·Arch Pharm Res·2006
4-observational
Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.
PMID 16951136·Cancer Res·2006
6-review
Identification of protein kinase C as an intermediate in Na,K-ATPase beta-subunit mediated lamellipodia formation and suppression of cell motility in carcinoma cells.
PMID 17535735·Cell Mol Biol (Noisy-le-grand)·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3821 MASTHEAD ST NE
ALBUQUERQUE, NM 87109 - Phone
- (505) 998-7400
Quick Facts
- NPI
- 1386028025
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile